Company: WHWK
Filing Date: 2025-01-31
Form Type: DEFM14A
Source: 0001193125-25-018470
Chunk: 246

Company: Whitehawk Therapeutics, Inc.
Filing Date: 2025-01-31
Form: DEFM14A
Chunk 246
---
 
 stock.                                                                                             |

| (7) | As of December 31, 2024, Mr. Maroun held options to purchase 133,999 shares of Company common stock. |

| (8) | As of December 31, 2024, Dr. Hirmand held options to purchase 105,038 shares of Company common stock. |

| (9) | As of December 31, 2024, Dr. Zhou held options to purchase 61,192 shares of Company common stock. |

- 174 -

EQUITY COMPENSATION PLAN INFORMATION Securities Authorized for Issuance Under Equity Compensation Plans We maintain our 2017 Stock Option and Incentive Plan, 2021 Plan, 2021 Employee Stock Purchase Plan (“2021 ESPP”), 2023 Inducement Equity Incentive Plan (“2023 Plan”), which was adopted without stockholder approval pursuant to Nasdaq Listing Rule 5635(c)(4), and the Amended and Restated 2014 Equity Incentive Plan, which was assumed by us in connection with the Reverse Merger in August 2021, approved by our stockholders. As of December 31, 2024, we had three active equity compensation plans and two inactive equity compensation plans with awards still outstanding at December 31, 2024. We also have warrants outstanding that were issued prior to the Reverse Merger to an individual pursuant to an equity compensation plan not approved by our stockholders.

| Plan Category                                                    |     | (a) Number of        
 securities           
 to be issued upon    
 exercise of          
 outstanding options, 
 warrants and         
 rights               |           |    |     | (b) Weighted      
 average           
 exercise price of 
 outstanding       
 options,          
 warrants and      
 rights            |       |     | (c) Number of         
 securities            
 remaining available   
 for future issuance   
 under                 
 equity                
 compensation plans    
 (excluding securities 
 reflected in column   
 (a))                  |           |    |
|:-----------------------------------------------------------------|:----|:---------------------|----------:|---:|:----|:------------------|------:|:----|:----------------------|----------:|---:|
| Equity compensation plans approved by security holders (1)(2)(3) |     |                      | 4,716,506 |    |     | $                 | 11.53 |     |                       | 1,823,798 | -4 |
| Equity compensation plans not approved by security holders